The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
AACR 2021 | Survival for patients with early-onset CRC
En Cheng, MD, MSPH, Yale University School of Public Health, New Haven, CT, gives an overview of his presentation on overall survival for patients with early-onset colorectal cancer (CRC), presented at AACR 2021. The study, which analyzed data from the National Cancer Database between 2004 and 2015, reported that early-onset CRC patients had better survival than patients diagnosed at ages 51-55, reinforcing the importance of CRC detection in younger populations. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.
